← back to search

Juan Liu

Shandong University of Traditional Chinese Medicine · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, Cancer, Lipids, and Metabolism, Epigenetics and DNA Methylation, and Mitochondrial Function and Pathology.
h-index
34
citations
6,539
works
193
NIH funding
primary concept
email

Recent publications

Mitigation of <i>P. gingivalis</i> -exacerbated intestinal inflammation by paeoniflorin through alteration of the gut microbiota
Microbiology Spectrum 2025cited by 4position: middledoi
COVID-19 and sepsis-related excess mortality in the United States during the first 3 years: a national-wide time-series study
American Journal of Epidemiology 2024cited by 7position: middledoi
Dissecting the roles of increased mRNA m6A methylation in autotetraploidization in Stevia rebaudiana
Plant Growth Regulation 2024cited by 3position: firstdoi
PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the Heart
Circulation 2021cited by 69position: middledoi
The TGF-β/HDAC7 axis suppresses TCA cycle metabolism in renal cancer
JCI Insight 2021cited by 34position: middledoi
Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers
Cancer Research 2021cited by 33position: middledoi
Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing
Nature Cell Biology 2020cited by 319position: middledoi
Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism
Nature 2019cited by 411position: middledoi
Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
Nature Communications 2019cited by 47position: middledoi
Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells
Nature Cell Biology 2018cited by 479position: middledoi
Tumor suppressor p53 and metabolism
Journal of Molecular Cell Biology 2018cited by 298position: firstdoi
Tumour-associated mutant p53 drives the Warburg effect
Nature Communications 2013cited by 432position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jason W. Locasale · North Central State College6 papers (2018–2021)Wenwei Hu · Rutgers, The State University of New Jersey2 papers (2013–2018)Charles M. Perou · Oryzon Genomics (Spain)2 papers (2019–2021)Zhaohui Feng · Rutgers, The State University of New Jersey2 papers (2013–2018)Qing Zhang · Gannon University2 papers (2019–2021)Cen Zhang · NYU Langone Health2 papers (2013–2018)Cheng Fan · North Carolina State University2 papers (2019–2021)Jeremy M. Simon · Dana-Farber Cancer Institute1 papers (2019–2019) · 1 papers (2021–2021)Jielin Yan · Memorial Sloan Kettering Cancer Center1 papers (2019–2019)Felicia Rustandy · Duke-NUS Medical School1 papers (2019–2019)Xiwei Wu · Tianjin University of Traditional Chinese Medicine1 papers (2018–2018)Jorge Andrade · Kite (United States)1 papers (2019–2019)Shengzhi Sun · Huazhong University of Science and Technology1 papers (2024–2024) · 1 papers (2018–2018)Maria V. Liberti · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2021–2021)Marcelo G. Bonini · Moffitt Cancer Center1 papers (2019–2019)Grace A. Hernandez · University of California, San Francisco1 papers (2020–2020)Jessica Holler · Emory University1 papers (2019–2019)Mei Kong · Jiangsu University1 papers (2020–2020)